NCT03093103View on ClinicalTrials.gov

Empagliflozin and Renal Oxygenation in Healthy Volunteers

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 16, 2017

Primary Completion Date

December 30, 2018

Study Completion Date

December 31, 2018

Conditions
Nephropathy
Interventions
DRUG

Empagliflozin 10 mg

Prescription of empagliflozin 10 mg once a day Follow-up of renal parameters including BOLD MRI

DRUG

Placebo

Prescription of a placebo once a day Follow-up of renal parameters including BOLD MRI

Trial Locations (1)

1011

Service de Néphrologie, Lausanne

All Listed Sponsors
lead

Centre Hospitalier Universitaire Vaudois

OTHER

NCT03093103 - Empagliflozin and Renal Oxygenation in Healthy Volunteers | Biotech Hunter | Biotech Hunter